{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T03:26:58Z","timestamp":1793158018810,"version":"4.5.0"},"reference-count":35,"publisher":"Society of Nuclear Medicine","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Nucl Med"],"published-print":{"date-parts":[[2020,4]]},"DOI":"10.2967\/jnumed.119.234187","type":"journal-article","created":{"date-parts":[[2019,9,27]],"date-time":"2019-09-27T22:15:15Z","timestamp":1569622515000},"page":"527-532","source":"Crossref","is-referenced-by-count":210,"title":["Head-to-Head Comparison of\n                    <sup>68<\/sup>\n                    Ga-PSMA-11 with\n                    <sup>18<\/sup>\n                    F-PSMA-1007 PET\/CT in Staging Prostate Cancer Using Histopathology and Immunohistochemical Analysis as a Reference Standard"],"prefix":"10.2967","volume":"61","author":[{"given":"Jonathan","family":"Kuten","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ibrahim","family":"Fahoum","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ziv","family":"Savin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ofer","family":"Shamni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gilad","family":"Gitstein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dov","family":"Hershkovitz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicola J.","family":"Mabjeesh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ofer","family":"Yossepowitch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eyal","family":"Mishani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Einat","family":"Even-Sapir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1602","published-online":{"date-parts":[[2019,9,27]]},"reference":[{"key":"2021051712144110000_61.4.527.1","doi-asserted-by":"publisher","DOI":"10.1007\/s00259-012-2298-2"},{"key":"2021051712144110000_61.4.527.2","doi-asserted-by":"publisher","DOI":"10.1016\/j.juro.2015.12.025"},{"key":"2021051712144110000_61.4.527.3","doi-asserted-by":"publisher","DOI":"10.1007\/s00259-014-2949-6"},{"key":"2021051712144110000_61.4.527.4","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1111\/bju.13540","article-title":"Prospective evaluation of 68gallium-prostate-specific membrane antigen positron emission tomography\/computed tomography for preoperative lymph node staging in prostate cancer","volume":"119","author":"van Leeuwen","year":"2017","journal-title":"BJU Int."},{"key":"2021051712144110000_61.4.527.5","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1016\/j.eururo.2015.12.051","article-title":"68Ga-PSMA positron emission tomography\/computed tomography provides accurate staging of lymph node regions prior to lymph node dissection in patients with prostate cancer","volume":"70","author":"Herlemann","year":"2016","journal-title":"Eur Urol."},{"key":"2021051712144110000_61.4.527.6","doi-asserted-by":"crossref","first-page":"1806","DOI":"10.1007\/s00259-017-3752-y","article-title":"The accuracy of 68Ga-PSMA PET\/CT in primary lymph node staging in high-risk prostate cancer","volume":"44","author":"\u00d6bek","year":"2017","journal-title":"Eur J Nucl Med Mol Imaging."},{"key":"2021051712144110000_61.4.527.7","doi-asserted-by":"publisher","DOI":"10.1007\/s00259-013-2525-5"},{"key":"2021051712144110000_61.4.527.8","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.115.154153"},{"key":"2021051712144110000_61.4.527.9","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.115.160382"},{"key":"2021051712144110000_61.4.527.10","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/s10354-017-0569-z","article-title":"68Ga-PSMA-11 PET\/CT: the rising star of nuclear medicine in prostate cancer imaging?","volume":"169","author":"Uprimny","year":"2019","journal-title":"Wien Med Wochenschr."},{"key":"2021051712144110000_61.4.527.11","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.116.173492"},{"key":"2021051712144110000_61.4.527.12","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1001\/jamaoncol.2019.0096","article-title":"Assessment of 68Ga-PSMA-11 PET accuracy in localizing recurrent prostate cancer: a prospective single-arm clinical trial","volume":"5","author":"Fendler","year":"2019","journal-title":"JAMA Oncol."},{"key":"2021051712144110000_61.4.527.13","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.116.172627"},{"key":"2021051712144110000_61.4.527.14","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.117.190157"},{"key":"2021051712144110000_61.4.527.15","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1007\/s00259-016-3573-4","article-title":"F-18 labelled PSMA-1007: biodistribution, radiation dosimetry and histopathological validation of tumor lesions in prostate cancer patients","volume":"44","author":"Giesel","year":"2017","journal-title":"Eur J Nucl Med Mol Imaging."},{"key":"2021051712144110000_61.4.527.16","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1007\/s00259-018-3952-0","article-title":"Advantage of 18F-PSMA-1007 over 68Ga-PSMA-11 PET imaging for differentiation of local recurrence vs. urinary tracer excretion","volume":"45","author":"Rahbar","year":"2018","journal-title":"Eur J Nucl Med Mol Imaging."},{"key":"2021051712144110000_61.4.527.17","doi-asserted-by":"crossref","first-page":"1929","DOI":"10.1007\/s00259-016-3447-9","article-title":"18F-labelled PSMA-1007 shows similarity in structure, biodistribution and tumour uptake to the theragnostic compound PSMA-617","volume":"43","author":"Giesel","year":"2016","journal-title":"Eur J Nucl Med Mol Imaging."},{"key":"2021051712144110000_61.4.527.18","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.118.212233"},{"key":"2021051712144110000_61.4.527.19","doi-asserted-by":"crossref","first-page":"2055","DOI":"10.1007\/s00259-018-4089-x","article-title":"Diagnostic performance of 18F-PSMA-1007 PET\/CT in patients with biochemical recurrent prostate cancer","volume":"45","author":"Rahbar","year":"2018","journal-title":"Eur J Nucl Med Mol Imaging."},{"key":"2021051712144110000_61.4.527.20","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1016\/j.eururo.2016.08.003","article-title":"EAU-ESTRO-SIOG guidelines on prostate cancer. Part 1: screening, diagnosis, and local treatment with curative intent","volume":"71","author":"Mottet","year":"2017","journal-title":"Eur Urol."},{"key":"2021051712144110000_61.4.527.21","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.nucmedbio.2017.07.006","article-title":"Continuation of comprehensive quality control of the itG 68Ge\/68Ga generator and production of 68Ga-DOTATOC and 68Ga-PSMA-HBED-CC for clinical research studies","volume":"53","author":"Amor-Coarasa","year":"2017","journal-title":"Nucl Med Biol."},{"key":"2021051712144110000_61.4.527.22","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1002\/jlcr.3732","article-title":"Fine-tuning of the automated [18F]PSMA-1007 radiosynthesis","volume":"62","author":"Shamni","year":"2019","journal-title":"J Labelled Comp Radiopharm."},{"key":"2021051712144110000_61.4.527.23","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/ph10040077","article-title":"Procedures for the GMP-compliant production and quality control of 18F-PSMA-1007: a next generation radiofluorinated tracer for the detection of prostate cancer","volume":"10","author":"Cardinale","year":"2017","journal-title":"Pharmaceuticals (Basel)."},{"key":"2021051712144110000_61.4.527.24","doi-asserted-by":"crossref","unstructured":"Rauscher I Kr\u00f6nke M K\u00f6nig M . Matched-pair comparison of 68Ga-PSMA-11 and 18F-PSMA-1007 PET\/CT: frequency of pitfalls and detection efficacy in biochemical recurrence after radical prostatectomy. J Nucl Med. June 28, 2019 [Epub ahead of print].","DOI":"10.2967\/jnumed.119.229187"},{"key":"2021051712144110000_61.4.527.25","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1007\/s00259-017-3631-6","article-title":"68Ga-PSMA-11 PET\/CT in primary staging of prostate cancer: PSA and Gleason score predict the intensity of tracer accumulation in the primary tumour","volume":"44","author":"Uprimny","year":"2017","journal-title":"Eur J Nucl Med Mol Imaging."},{"key":"2021051712144110000_61.4.527.26","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s40644-016-0072-6","article-title":"68Ga-PSMA ligand PET\/CT in patients with prostate cancer: how we review and report","volume":"16","author":"Rauscher","year":"2016","journal-title":"Cancer Imaging."},{"key":"2021051712144110000_61.4.527.27","doi-asserted-by":"publisher","DOI":"10.1007\/s00259-015-3078-6"},{"key":"2021051712144110000_61.4.527.28","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1148\/rg.2018170108","article-title":"Prostate-specific membrane antigen PET: clinical utility in prostate cancer, normal patterns, pearls, and pitfalls","volume":"38","author":"Hofman","year":"2018","journal-title":"Radiographics."},{"key":"2021051712144110000_61.4.527.29","doi-asserted-by":"publisher","DOI":"10.2307\/2529310"},{"key":"2021051712144110000_61.4.527.30","doi-asserted-by":"publisher","DOI":"10.1016\/j.eururo.2011.08.029"},{"key":"2021051712144110000_61.4.527.31","doi-asserted-by":"crossref","first-page":"e259","DOI":"10.1016\/S1470-2045(12)70084-0","article-title":"Short-term androgen deprivation therapy for patients with intermediate-risk prostate cancer undergoing dose-escalated radiotherapy: the standard of care?","volume":"13","author":"Zumsteg","year":"2012","journal-title":"Lancet Oncol."},{"key":"2021051712144110000_61.4.527.32","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.117.203257"},{"key":"2021051712144110000_61.4.527.33","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.115.169243"},{"key":"2021051712144110000_61.4.527.34","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1007\/s00259-017-3670-z","article-title":"68Ga-PSMA PET\/CT: joint EANM and SNMMI procedure guideline for prostate cancer imaging: version 1.0","volume":"44","author":"Fendler","year":"2017","journal-title":"Eur J Nucl Med Mol Imaging."},{"key":"2021051712144110000_61.4.527.35","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1007\/s00259-018-3989-0","article-title":"18F-PSMA-1007 PET\/CT at 60 and 120 minutes in patients with prostate cancer: biodistribution, tumour detection and activity kinetics","volume":"45","author":"Rahbar","year":"2018","journal-title":"Eur J Nucl Med Mol Imaging."}],"container-title":["Journal of Nuclear Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.2967\/jnumed.119.234187","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,17]],"date-time":"2021-05-17T16:47:10Z","timestamp":1621270030000},"score":1,"resource":{"primary":{"URL":"http:\/\/jnm.snmjournals.org\/lookup\/doi\/10.2967\/jnumed.119.234187"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,9,27]]},"references-count":35,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2020,4,1]]},"published-print":{"date-parts":[[2020,4]]}},"alternative-id":["10.2967\/jnumed.119.234187"],"URL":"https:\/\/doi.org\/10.2967\/jnumed.119.234187","relation":{},"ISSN":["0161-5505","2159-662X"],"issn-type":[{"value":"0161-5505","type":"print"},{"value":"2159-662X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,9,27]]}}}